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Summary
AIMS OF THE STUDY: Coronavirus disease 2019
(COVID-19) pandemic has an ongoing severe impact on
health care, but there is a lack of information on COVID-19
and its effect on organ donation and solid organ transplan-
tation. Early in the pandemic, Swisstransplant, the Swiss
National Foundation for Organ Donation and Transplan-
tation, set up a national stepwise shutdown approach to
avoid a collapse of transplant activities during phases of
the pandemic with sufficient available healthcare capaci-
ties. The approach allowed regional adaptation of trans-
plant-associated activities depending on available health-
care capacities, instead of implementing a rigid centralistic
system. The aim of this study was to describe the stepwise
shutdown approach and to determine whether this flexible
approach would be helpful for avoiding complete cessa-
tion of transplant activities during a pandemic.
METHODS: A retrospective nationwide study was con-
ducted to evaluate donor procurement and solid organ
transplantation activity in Switzerland during the
COVID-19 pandemic (1 January to 31 May 2020). To as-
sess the impact of the flexible stepwise shutdown plan
on overall transplantation activity in Switzerland, we com-
pared total and individual numbers of transplanted organs
during the first wave of the pandemic with the transplant
activity immediately before the pandemic.
RESULTS: The pandemic evolved heterogeneously
across Swiss cantons, severely affecting western cantons
and the Ticino. Overall, there was a reduction in deceased
donor transplants in Switzerland of 16.7% in March and
April 2020 (during the pandemic) compared with January
and February 2020 (prior to the pandemic), the decline
mostly driven by kidney transplants (−27.6%) and to a
lesser extent by transplants of vital organs (heart, lungs,
liver) (−5.9%). In May 2020, solid organ transplantation
activity in Switzerland again exceeded the average of pre-
pandemic months (January and February), with 35 trans-
planted organs, but the increase from April to May 2020
was exclusively driven by liver and kidney transplants.
CONCLUSION: The Swiss stepwise shutdown approach
in organ donation and transplantation helped to maintain a
limited national organ procurement and vital organ trans-
plant activity, avoiding a complete nationwide shutdown of
organ donation and transplant activity. We therefore pro-
pose a flexible shutdown approach that regulates trans-
plant activities dependent on regional healthcare re-
sources rather than uniform centralistic regulations. This
approach proved to be especially useful during a regional
heterogeneously evolving pandemic.
Keywords: COVID-19, organ allocation, organ donation,
SARS-CoV-2, organ transplantation
Introduction
In December 2019, a novel coronavirus, severe acute res-
piratory syndrome coronavirus 2 (SARS-CoV-2), emerged
in Wuhan, in the Chinese Province of Hubei, causing an
unprecedented pandemic [1, 2]. The World Health Organi-
zation (WHO) labelled the disease caused by SARS-CoV-2
coronavirus disease 2019 (COVID-19), and declared
COVID-19 a public health emergency of international con-
cern on 30 January 2020 [2]. The COVID-19 pandemic
has so far had a tremendous impact worldwide, with major
consequences for health care, the world economy and so-
cial affairs. There is a massive impact on healthcare re-
sources, in particular, the need for intensive care unit (ICU)
beds and mechanical ventilatory support [2]. However, it
was unknown how COVID-19 effects organ donation and
solid organ transplantation in the future [3]. Recently,
Loupy et al published data that quantified the contempo-
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rary impact of the COVID-19 pandemic on organ dona-
tion and transplantation in France and the USA, showing a
strong association between the increase of COVID-19 in-
fections and the reduction in transplant activity [4]. De-
ceased organ transplant procedures dropped after the start
of the COVID-19 pandemic by 90.6% in France and by
51.1% in the USA [4]. Further, the authors reported a sig-
nificant decline in solid organ transplantation rates even in
regions with a low COVID-19 prevalence [4].
In Europe, Italy was the first country severely struck by
the pandemic [5]. Given the fact that thousands of North-
ern Italian citizens daily cross the Italian-Swiss border to
the Canton of Ticino, the southernmost canton of Switzer-
land to commute to work, it was expected that Switzerland
would face a similar healthcare crisis to Italy. On 25 Feb-
ruary 2020, the first SARS-CoV-2 positive individual was
diagnosed in the Swiss Canton of Ticino [6]. Like Italy,
where mainly the northern part and particularly Lombardy
were affected, the COVID-19 pandemic in Switzerland al-
so evolved heterogeneously in different regions. Of the
8,570,000 Swiss citizens, two thirds populate the German-
speaking areas in the north and north-east, just over 20%
live in the predominately French-speaking cantons in west-
ern Switzerland, and less than 10% inhabit the Italian-
speaking Canton of Ticino in south Switzerland on the
border with Italy. By far the highest incidences of SARS-
CoV-2 infection were recorded in the French- and Italian-
speaking cantons, with an incidence of more than 100 con-
firmed cases per 10,000 inhabitants in the Canton of Gene-
va, closely followed by the Canton of Ticino with more
than 90 cases per 10,000 inhabitants from March to May
2020 [7]. The peak of the pandemic in terms of hospitali-
sations occurred on 2 April 2020 [7].
When the pandemic hit Switzerland, resources for organ
donation and transplantation had to be evaluated. Swis-
stransplant, the Swiss National Foundation for Organ Do-
nation and Transplantation with headquarters in Berne,
decided to establish a nationwide stepwise shutdown ap-
proach, which allows adaption of transplant-associated ac-
tivities regionally, dependent on local healthcare capaci-
ties. The major goal was to coordinate transplant activities
in a structured manner in order to provide a continuous op-
portunity for critically ill patients on the national transplant
waiting list to receive a life-saving transplantation. Fur-
thermore, guidelines were established on how to proceed
with deceased and living organ and tissue donors, guided
by infectious diseases specialists from all Swiss transplant
centres.
We assumed that Swiss organ donation is structured in a
similar way to that of France, with a centrally organised
national organ allocation, and that we would therefore see
similar consequences. Given the recently published detri-
mental French data on organ procurement and transplan-
tation, we aimed at analysing the effect of the COVID-19
pandemic on the organ donation rate and solid organ trans-
plantation in Switzerland. With this in mind, we looked
at whether the Swiss stepwise shutdown approach allowed
transplant activities to be maintained at an acceptable level
during the pandemic. We were interested to learn if our
new approach enabled at least transplantation of vital or-
gans for critically ill patients to be maintained. Briefly, in
Switzerland, there are six transplant centres, two in the
French speaking part (Geneva and Lausanne) and four in
the German speaking part (Basel, Berne, St Gallen and
Zurich). Transplant centres in Basel and St Gallen offer
kidney transplantation only; whole pancreas and islet
transplantation is available only in Geneva and Zurich. Or-
gan procurements are made at the level of the five universi-
ty hospitals and in nine tertiary hospitals. Of these tertiary
hospitals, there are three hospitals in the French-speaking
part (Fribourg, Sion and Neuchâtel), five hospitals in the
German speaking part (Aarau, Chur, Luzern, St Gallen and
Winterthur) and one hospital in the Italian speaking part
(Lugano).
Patients and methods
A retrospective nationwide study was conducted to eval-
uate donor procurement and solid organ transplantation
activity in Switzerland during the COVID-19 pandemic
(from 1 January 2020 to 31 May 2020) under a newly de-
veloped stepwise shutdown approach for procurement hos-
pitals and transplant services.
Measures to address safety of solid organ transplantation
started with implementation of a nationwide stepwise shut-
down approach for organ procurement that allowed region-
al adaption of transplant-associated activities dependent on
local healthcare capacities. The goal was to avoid a com-
plete cessation of organ donation after brain death (DBD)
and donation after circulatory death (DCD) (table 1).
The availability of donor detection and organ procurement
was checked by daily e-mail correspondence among the
heads of the five regional donor procurement networks and
lead intensive care unit (ICU) physicians at hospitals with
procurement facilities. The daily update provided a nation-
al overview on decisions taken by the procurement hospi-
tals and transplant centres in charge.
The stepwise shutdown approach was put into operation
during the pandemic at all Swiss transplant centres as of
13 March 2020. It covered living donor transplantation
and deceased donor detection in Switzerland, and also the
modality of acceptance and availability of potential pro-
curement of offers from outside Switzerland by transplant
teams at each centre. For living and deceased donors, we
implemented the following steps in order to avoid a com-
plete shutdown and to give a national overview on the
availability of regional resources as shown in table 2.
As of 17 March 2020, all possible/potential donors were
reported to Swisstransplant. The case-to-case triage carried
out by the medical advisor of Swisstransplant led to the en-
rolment of potential donors based on the actual situation
Table 1: The steps of the “Swiss COVID-19 pandemic stepwise shut-






Centralised donor evaluation by the Medical
Director of Swisstransplant based on quality








Donor detection and procurement no longer
available.
DBD = donation after brain death; DCD = donation after circulatory
death
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on the waiting list and the availabilities of transplant pro-
grammes.
Furthermore, a special “Swiss Pandemic Urgent Status”
was accepted by the three liver transplantation centres and
the Swiss Federal Office of Public Health (FOPH) in the
limited time period of the national lockdown. Since the
Model for End-stage Liver Disease (MELD) criteria are
rather weak in selecting patients, the Swiss Pandemic Ur-
gent Status was mainly applied to patients at high risk
(mortality) and expected short stay on the ICU and then se-
lected, mainly based on the actual MELD or Standard Ex-
ceptions(SE)-MELD value.
Swisstransplant remained actively involved on an interna-
tional level, with the intention to facilitate cross-border or-
gan sharing. Team availabilities and logistic facilities were
checked daily, and the interest of Switzerland in accepting
foreign donor organs was communicated to international
partners weekly.
For foreign donor organ offers, we defined stepwise mea-
sures as presented in table 3. Even though centres aimed
to avoid travel of the procurement teams, in multiple cases
(i.e., heart and lung procurement), Swiss teams went to the
foreign donor hospital for procurement.
Further administrative and organisational steps were in-
troduced. ICU donor coordinators, on the Swisstransplant
payroll, were secondarily enrolled at the level of hospitals
and partly exempt from their tasks on the donor procure-
ment side. In addition, the national coordination team
(mostly ICU-trained nurse specialists) were partly enrolled
at the level of hospital ICUs to provide staff support, aim-
ing to avoid cancellation of transplant activity due to short-
ness of specialised staff. Subsidiarity between individual
transplant teams due to the local pandemic situation was
discussed, i.e., in Geneva, where all transplant activities
were halted, except for urgent cases only [8]. Swiss liver
transplant centres collaborated and ensured that any centre
not being able to perform transplants for COVID-19-relat-
ed logistical reasons would be supported, even by poten-
tially transferring patients to the other two still operating
centres for the transplant procedure.
Table 2: The steps of the “Swiss COVID-19 pandemic stepwise shut-
down approach” that were applied to organ transplant programmes.
Step Action Result
1 Stop all living
donation trans-
plantation





Pancreas/islets transplantation from de-
ceased donors no longer available
3 Stop kidney
transplantation
Kidney transplantation from deceased







Only elective transplantations of vital or-
gans or urgent transplantations to be per-
formed
5 Stop all non-ur-
gent transplan-
tations
Only urgent transplantations to be per-
formed (heart, kidney, liver, lung)
6 Stop all trans-
plantation activ-
ity
Transplantation no longer available
Statistical analysis
Epidemiological data on COVID-19 in Switzerland were
extracted from www.corona-data.ch. The COVID-19
prevalence (cases per 10,000 permanent resident popula-
tion) in each canton was used to visualise the spread of
COVID-19 across Switzerland. We analysed organ pro-
curement and transplantation activity according to the
Swisstransplant stepwise shutdown approach for the peri-
od of 17 March 2020 to 11 May 2020 (data were updated
daily from 17 March 2020 to 4 April 2020, and weekly
from 29 April 2020 to 5 May 2020). Only publicly avail-
able information was used for analysis, hence not requiring
additional institutional review board approval. To show
the targeted application of the stepwise shutdown, the sta-
tus according to the three approaches for all 14 hospitals
providing organ procurement and/or transplantation pro-
grammes is presented.
To assess the impact of the COVID-19 pandemic on the
overall transplantation activity in Switzerland, we com-
pared total and individual numbers of transplanted organs
with the total number of ascertained COVID-19 cases over
the period from 1 January 2020 to 31 May 2020. Data on
transplanted organs from deceased donors were accessed
by an automated database query in the Swiss Organ Allo-
cation System (SOAS) and arranged using the freely avail-
able software R (version 3.6.0). Numbers were grouped by
organ and month. Multi-organ transplantation counted to
each of the respective organ and “double transplantations”
(i.e., both kidneys to the same recipient) counted as two or-
gans.
Results
Availability of organ donor detection and procure-
ment, and transplant programme availability during
the pandemic
Under normal circumstances prior to the pandemic, a total
of 14 centres (university hospitals and tertiary hospitals)
provide identification of potential deceased organ donors
and procurement services. Figure 1 represents a snapshot
of the availability of deceased organ donor procurement
Table 3: The steps of the “Swiss COVID-19 pandemic stepwise shut-
down approach” that were applied to cross-border organ exchange.
Step Action Result




Elective transplantations from cross-border
living donors no longer available




Pancreas/islets and small bowel transplan-
tation from cross-border deceased donors
no longer available
3 Stop import of
kidney grafts
Kidney transplantation from cross-border
deceased donors no longer available, in-
cluding kidney/pancreas and kidney/islets
4 Selected im-
port of vital or-
gans only
Only elective transplantations of foreign vi-
tal organs
5 Selected im-




Only life-saving transplantations of foreign
organs to be performed (heart, liver, lung) in





Transplantation utilizing foreign donor or-
gans no longer available
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across Switzerland on 6 April 2020, during the peak of the
pandemic. In north-eastern cantons of Switzerland, where
COVID-19 prevalence was below the national average,
identification of potential deceased organ donors and pro-
curement service was available as usual in all hospitals,
whereas in the western and southern cantons all existing
DCD programmes were completely discontinued. The
DBD programmes in the western and southern cantons re-
mained available only in the three large university hospi-
tals of Geneva (University Hospital Geneva, HUG), Lau-
sanne (University Hospital Lausanne, CHUV), and Berne
(Inselspital, University Hospital Berne).
During normal conditions, a total of six university or ter-
tiary hospitals provide transplant programmes for one or
several organs, including kidney and liver transplantation
from living donors. Figure 2 shows the availability of or-
gan transplant programmes across Switzerland from 9
March 2020 to 11 May 2020, according to the stepwise
shutdown approach used during the pandemic in Switzer-
land. Transplantation from living donors, pancreas/islets
transplantation and kidney transplantation was stopped
from 16 March to 13 April in all centres nationwide. At
HUG in Geneva and CHUV in Lausanne – located in re-
gions with the highest COVID-19 prevalence – transplan-
tation was limited to vital organs and urgently listed pa-
tients only during the same period. At HUG, transplant
activities even completely ceased for one week. From mid-
April, transplant activities were resumed step-by-step, first
at centres in the least affected eastern part of Switzerland
(i.e., in Zurich), subsequently also at centres located else-
where in Switzerland, and ultimately in Geneva.
The limited availability of the Swiss organ transplant pro-
grammes, particularly in the month of March, is reflected
in substantially reduced organ importation. In the months
of April and May, organ importation increased strongly,
reaching high figures (six imported organs in April and
seven in May). Every fifth organ transplanted in Switzer-
land was retrieved at foreign procurement centres and im-
ported to Switzerland in April and May 2020, whereas pri-
or to the pandemic, in January and February 2020, the
percentage of imported organs was below 10%. The num-
ber of exported organs shows an opposite development,
with six organs (19%) exported in March 2020, which is
clearly above the usual monthly average (1–5%). This re-
flects the maintained ability of donor detection and pro-
curement activities in about half of the Swiss procurement
centres even during the pandemic’s peak in Switzerland.
Organs procured in Switzerland during this period were
made available for patients in other European countries as
transplant capacities were limited in Switzerland (fig. 3).
Impact on solid organ transplantation
There was an overall reduction in deceased donor trans-
plantation in Switzerland of 16.7%, when March and April
2020 (during the pandemic) were compared with January
and February 2020 (prior to the pandemic). This decline
was mostly driven by kidney transplantation (−27.6%) and
to a lesser extent by transplants of the vital organs heart,
lungs, and liver (−5.9%). In May 2020, solid organ trans-
plantation activity in Switzerland exceeded the average
of the pre-pandemic months January and February, with
35 transplanted organs. However, the increase from April
Figure 1: Availability of DCD programmes (left column) and DBD programmes (right column) in the 14 procurement centres in Switzerland on
16 April 2020, according to the stepwise shutdown approach for organ procurement described in “Patients and methods” (table 1). The preva-
lence of COVID-19 for each Swiss canton is shown per 10,000 inhabitants on 6 April 2020 (www.corona-data.ch). In all active procurement
programmes, a centralised national case-by-case triage was applied between 17 March and 11 May 2020 (step 1, not shown).CHUV = Univer-
sity Hospital Lausanne; DBD = donation after brain death; DCD = donation after circulatory death; EOC = Cantonal Hospital Lugano; HDF =
Cantonal of Hospital of Valais; HFR = Cantonal Hospital Fribourg; HNP = Cantonal Hospital Neuchatel; HUG = University Hospital Geneva; In-
sel = University Hospital Berne; KSA = Cantonal Hospital Aarau; KSG = Cantonal Hospital of Graubünden; KSW = Cantonal Hospital Win-
terthur; KSSG = Cantonal Hospital St Gallen; LUKS = Cantonal of Hospital of Lucerne; USB = University Hospital Basel; USZ = University
Hospital Zurich
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to May 2020 was exclusively driven by liver and kidney
transplantation (fig. 4).
During the study period, no patient with respiratory failure
secondary to severe COVID-19 underwent lung transplan-
tation. Furthermore, no patient with COVID-19 underwent
solid organ transplantation. To the authors’ knowledge,
no transplant recipient developed COVID-19 in the early
post-transplant stage during the study period; however, no
systematic nationwide SARS-CoV-2 screening programme
was in place.
Discussion
To the authors’ knowledge, we describe for the first time
a nationwide stepwise shutdown approach for organ do-
nation and transplantation in response to the COVID-19
pandemic. Our approach included a daily communication
by email on the current availability of donation and trans-
plantation programmes for each hospital, and the avail-
ability of cross-border organ exchange. We are convinced
that this constant communication was crucial and helped
to raise the awareness that hospital occupancy rates due to
COVID-19 varied greatly from region to region, and thus
the availability of resources for organ donation and trans-
plantation also varied. We believe that our approach helped
to maintain a reduced organ procurement activity in about
half of the Swiss procurement centres. On a national lev-
el, our approach facilitated maintaining the transplantation
activity for vital organs and urgently listed patients on the
national waiting list, preventing a steeper decline of trans-
plant numbers in Switzerland during the first wave of the
COVID-19 pandemic.
In general, the deceased donor rate in Switzerland is rather
low, with fewer than 20 deceased donors per million steady
population [9]. In 2019, 36% of the deceased donors were
DCD Maastricht III donors (awaiting cardiocirculatory
death) [10]. French- and Italian-speaking parts of Switzer-
land contributed almost 40% to the total number of de-
ceased donors in year 2019 [10]. However, the French-
and Italian-speaking parts of Switzerland have were the ar-
eas mainly affected by the pandemic. Therefore, shutting
down all DCD programmes and donor detection in four
large procurement hospitals in these areas because of the
COVID-19 pandemic had major implications for solid or-
gan transplantation activity in Switzerland.
To date, data on the impact of the COVID-19 pandemic
on worldwide organ donation and transplantation activity
are limited. The negative impact of the pandemic on trans-
plant activity in France and the USA was previously re-
ported by Loupy and coworkers, revealing a more than
90% decline in deceased organ transplant procedures in
France and more than 50% in the USA [4]. Switzerland has
the higher COVID-19 prevalence at 27.7 compared with
18.6 and 22.1 in France and the USA, respectively. France
and Switzerland have comparable healthcare systems and
centrally organised national organ allocation. In contrast
to other countries, it was possible to maintain transplant
activities in Switzerland. We argue that the implementa-
tion of a flexible shutdown approach, which takes regional
differences of healthcare capacities during a pandemic in-
to account, was a crucial step to avoid dramatic decreas-
es in transplant activity. The daily coordination by Swis-
stransplant, in close collaboration with the procurement
hospitals and transplant centres, has been essential to this
approach. The daily updates by Swisstransplant also pro-
vided an overview on national donation activity (number
of donors evaluated/enrolled), foreign offers (cross-border
organ exchange), as well as the situation on the national
wait list (patients in urgent status, medical status of pa-
tients on the national wait list awaiting vital organ trans-
plants) within the last 24 hours.
Due to the shutdown of the DCD programmes on the donor
side in the French- and Italian-speaking parts of Switzer-
land on 18 March 2020, a case-by-case triage of potential
donors (step 3) was implemented immediately. A careful
selection of extended criteria organ donor offers was also
essential in view of the limited resources in times of a pan-
demic, balanced with the need of ongoing transplantation
of vital organs and urgently listed transplant candidates.
This prompt and very close involvement of relevant na-
tional stakeholders by Swisstransplant on the donor and
transplantation side was probably the main reason for the
success of the stepwise shutdown approach. Swisstrans-
Figure 2: Availability of the four transplant centres with multiple organ transplant programmes in Switzerland according to the stepwise shut-
down approach described in “Patients and methods” (table 2) over time. Shown here are weekly statuses from 9 March 11 to May 2020.CHUV
= University Hospital Lausanne; HUG = University Hospital Geneva; Insel = University Hospital Berne; USZ = University Hospital Zurich
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plant’s lead role and the knowledge that in selected areas
in Switzerland – mainly in the German speaking part – re-
sources were available, was important. During this time,
we experienced an impressive level of commitment and
solidarity across the country, with increased continuous
communication and real-time adaptation of procurement
and transplant activity. As chair of the European Commit-
tee on Organ Transplantation (CD-P-TO), Swisstransplant
initiated an exchange of relevant documents through the
platform created by the European Directory for Quality of
Medicine and Health Care (EDQM), which was used by
many other European countries. In order not to discard
good quality organs, Swisstransplant approached its part-
ners through FOEDUS, the leading platform for facilitat-
ing exchange of organs in Europe (covering a population
of 372 million inhabitants), to stimulate import and export,
and overcome logistic issues during the pandemic.
In view of limited resources, Swisstransplant was able,
with support by the FOPH, to review allocation modalities,
introducing a timely limited “Swiss Pandemic Urgent Sta-
tus” for liver transplant recipients, which allowed the ex-
perts to establish a tailored approach in patient selection
and provided access to transplantation to those patients
with a suspected high wait list mortality but hopefully a
shorter post-transplantation ICU stay [8]. The effect of re-
duced donor volume on resource allocation has very re-
cently been discussed for cardio-thoracic transplantation,
also [10].
It is important to emphasise that the introduction of a
stepwise shutdown approach, moving forward in different
steps at individual centres also allowed potential re-open-
ing of individual programmes to be to some degree an-
ticipated, based on regional pandemic status and local re-
sources. In this context, kidney transplantation has been
re-launched very early in most centres, after almost 5
Figure 3: Number of foreign organs imported (upper chart) and exported (lower chart) over time. For total numbers, in brackets, import share
in percent of all transplanted organs in Switzerland, and export share in percent of all transplanted organs from Swiss deceased donors, re-
spectively, are given. From January to May 2020, organs were exchanged with France (18 organs), Italy (3 organs), Spain (2 organs), the
United Kingdom (2 organs), and with Germany, Sweden, and Lithuania (1 organ each).
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weeks of shutdown, reaching activities similar to those be-
fore the COVID-19 pandemic in May. Furthermore, donor
procurement programmes were re-opened very fast as a re-
sult of the involvement of ICU staff at procurement centres
and their willingness to respond to the need of donor or-
gans for patients on the national wait list.
As mentioned before, the stepwise shut down approach al-
so allowed a certain timely limited subsidiarity of donor
coordinators (mostly trained ICU staff) and Swisstrans-
plant medical staff to support local ICUs and transplant
centres.
Strength and limitations
It is the strength of our study that it describes for the first
time a nationwide stepwise shutdown approach for organ
donation and transplantation in response to the COVID-19
pandemic. But our study has several limitations due to its
retrospective design and small patient numbers. Given the
descriptive nature of this national study, one cannot com-
pletely rule out that the development in organ donation and
solid organ transplantation activity seen would have been
different without the pandemic, thus a causative effect of
our stepwise shutdown approach on organ donation and
transplant activity is not proven. It also remains debatable
if the complete shutdown of the nationwide kidney trans-
plant activity in Switzerland was absolutely needed at the
start of the pandemic. Even though this step helped to redi-
rect resources within the healthcare system under pressure
of the pandemic, the 27.6% fall in kidney transplant activ-
ity during the pandemic placed an extreme burden on pa-
tients on the national wait list for kidney transplantation.
In the case of a second wave of the pandemic, relocation
of (staff) resources among centres should probably be the
preferred approach. Furthermore, the authors acknowledge
that the Swiss healthcare system is somewhat unique; thus,
comparisons with other countries are by some means lim-
ited. Despite the high incidence of SARS-CoV-2 infection
in Switzerland in spring 2020, the Swiss healthcare sys-
tem overall coped well, ICU beds were available through-
out the pandemic, and plans for expanding ICU beds were
in place.
Conclusion
In summary, the Swiss SARS-CoV-2 pandemic stepwise
shutdown approach in organ donation and transplantation
assisted to maintain – at least – limited organ procurement
and vital organ transplantation, avoiding a complete na-
tional shutdown of organ donation and transplant activity
in Switzerland. We propose our approach of a coordinated
triage as a suitable tool also for other countries with com-
parable healthcare systems and a centrally organised na-
tional organ allocation system in times of a pandemic,
despite certain limitations. Our approach may also be ex-
tended internationally, as Swisstransplant has successfully
done through FOEDUS, avoiding loss of good quality or-
gans due to a pandemic situation and lack of resources.
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Switzerland. COVID-19 = coronavirus disease 2019.
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